1-20 of 120
Sort by
News

Etranacogene Dezaparvovec Bests Extended Half-Life Factor IX Products in Hemophilia B Prophylaxis

Katie Robinson
Published: 2024
Abstract
February 2024
View News titled, Etranacogene Dezaparvovec Bests Extended Half-Life Factor IX Products in Hemophilia B Prophylaxis
News

Health Disparities Persist in Hemophilia Life Expectancy

Lara C. Pullen, PhD
Published: 2024
Abstract
January 2024
View News titled, Health Disparities Persist in Hemophilia Life Expectancy
News

Better Scoring Systems Needed for Bleeding Risk Assessment in Patients With Cancer

Ruth Jessen Hickman, MD
Published: 2023
Abstract
January 2024
View News titled, Better Scoring Systems Needed for Bleeding Risk Assessment in Patients With Cancer
News

Age Linked to Desmopressin Response in von Willebrand Disease

Thomas R. Collins
Published: 2023
Abstract
January 2024
View News titled, Age Linked to Desmopressin Response in von Willebrand Disease
News

Emicizumab Effective as a Hemophilia A Prophylaxis in Infants

Leah Lawrence
Published: 2023
Abstract
January 2024
View News titled, Emicizumab Effective as a Hemophilia A Prophylaxis in Infants
News

Ultrasound May Be Useful to Assess Subclinical Synovial Inflammation in Hemophilia

Ruth Jessen Hickman, MD
Published: 2023
Abstract
December 2023
View News titled, Ultrasound May Be Useful to Assess Subclinical Synovial Inflammation in Hemophilia
News

Valoctocogene Roxaparvovec May Provide Lower Bleeding Rates Than Emicizumab in Severe Hemophilia A

Katie Robinson
Published: 2023
Abstract
October 2023
View News titled, Valoctocogene Roxaparvovec May Provide Lower Bleeding Rates Than Emicizumab in Severe Hemophilia A
News

Switching to Different FVIII Product Not Associated with Anti-FVIII Inhibitor Development

Anna Azvolinsky, PhD
Published: 2023
Abstract
September 2023
View News titled, Switching to Different FVIII Product Not Associated with Anti-FVIII Inhibitor Development
News

Fitusiran Significantly Reduces Bleeding Events, Improves HRQoL in Hemophilia A, B

Brandon May
Published: 2023
Abstract
Mid-July 2023
View News titled, Fitusiran Significantly Reduces Bleeding Events, Improves HRQoL in Hemophilia A, B
News

STASEY Study Confirms Safety of Emicizumab Prophylaxis in Hemophilia A With FVIII Inhibitors

By Khylia Marshall
Published: 2023
Abstract
March 2023
View News titled, STASEY Study Confirms Safety of Emicizumab Prophylaxis in Hemophilia A With FVIII Inhibitors
News

Which Modality Is Preferred in Hemophilia: Factor or Non-Factor Prophylaxis?

Kimberly J. Retzlaff
Published: 2023
Abstract
March 2023
View News titled, Which Modality Is Preferred in Hemophilia: Factor or Non-Factor Prophylaxis?
News

Low VWF Levels Linked With Lower CVD Risk

Leah Lawrence
Published: 2023
Abstract
February 2023
View News titled, Low VWF Levels Linked With Lower CVD Risk
News

Emicizumab Can Be Used Without FVIII Inhibitors in Infants With Severe Hemophilia

Ruth Jessen Hickman, MD
Published: 2022
Abstract
Mid-January 2023
View News titled, Emicizumab Can Be Used Without FVIII Inhibitors in Infants With Severe Hemophilia
News

Study Reveals Approach to Testing Adolescent Girls for VWD

Anna Azvolinsky, PhD
Published: 2022
Abstract
Mid-January 2023
View News titled, Study Reveals Approach to Testing Adolescent Girls for VWD
News

Untreated Bleeds Add to Disease Burden in Hemophilia A

Leah Lawrence
Published: 2022
Abstract
January 2023
View News titled, Untreated Bleeds Add to Disease Burden in Hemophilia A
News

TA More Effective, Affordable Than rVWF for VWD-Related Heavy Menstrual Bleeding

Leah Lawrence
Published: 2022
Abstract
Mid-January 2023
View News titled, TA More Effective, Affordable Than rVWF for VWD-Related Heavy Menstrual Bleeding
News

Efgartigimod Promotes Sustained Platelet Count Response in iTP

Ruth Jessen Hickman, MD
Published: 2022
Abstract
February 2023
View News titled, Efgartigimod Promotes Sustained Platelet Count Response in iTP
News

Preterm Neonates Display Decreased Platelet Activation, No Increased Risk of Bleeds

Ruth Jessen Hickman, MD
Published: 2022
Abstract
Mid-November 2022
View News titled, Preterm Neonates Display Decreased Platelet Activation, No Increased Risk of Bleeds
News

Caplacizumab Reduces Exacerbations and Refractoriness in Real-World iTTP

Brandon May
Published: 2022
Abstract
November 2022
View News titled, Caplacizumab Reduces Exacerbations and Refractoriness in Real-World iTTP
News

Pregnancy Does Not Increase Risk of Severe Bleeding in ITP

Leah Lawrence
Published: 2022
Abstract
November 2022
View News titled, Pregnancy Does Not Increase Risk of Severe Bleeding in ITP